A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
Clinical trial NCT06008054 · RECRUITING
Trial details
- NCT number
- NCT06008054
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2026-12-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.